Uehara Tetsuya, Xi Peng Xing, Bennett Brydon, Satoh Yoshi, Friedman Glenn, Currin Robert, Brenner David A, Lemasters John
Department of Medicine, University of North Carolina at Chapel Hill, USA.
Transplantation. 2004 Aug 15;78(3):324-32. doi: 10.1097/01.tp.0000128859.42696.28.
Orthotopic liver transplantation (OLT) requires cold ischemic storage followed by warm reperfusion. Although c-Jun N-terminal kinase (JNK) is rapidly activated after OLT, the functional consequences of JNK activation are unknown. The aim of this study was to address the role of JNK after OLT using the selective JNK inhibitor CC-401.
Donors, recipients, or stored liver explants were treated with vehicle or JNK inhibitor before OLT by an arterialized two-cuff method with 40 hours of cold storage. Recipients were assessed for 30-day survival, and graft injury was assessed over time by hepatic histology, serum transaminases, caspase 3 activation, cytosolic cytochrome c, and lipid peroxidation.
Survival after OLT increased after donor plus storage and storage only treatment with JNK inhibitor (P<0.05). Treatment of recipient only did not improve survival. Increased survival correlated with improved hepatic histology and serum aspartate aminotransferase levels. JNK inhibition significantly decreased nonparenchymal cell killing at 60 minutes after reperfusion (P<0.05) and pericentral necrosis at 8 hours after reperfusion (P<0.01). JNK inhibition decreased cytochrome c release, caspase 3 activation (P<0.05), and lipid peroxidation (P<0.05). JNK inhibition also transiently blocked phosphorylation of c-Jun at 60 minutes after reperfusion (P<0.05) without affecting other MAPK signaling, including p-38 and Erk activation.
JNK inhibition decreases hepatic necrosis and apoptosis after OLT, suggesting that JNK activation promotes cell death by both pathways. Inhibition of JNK may be a new therapeutic strategy to prevent liver injury after transplantation.
原位肝移植(OLT)需要冷缺血保存,随后进行热再灌注。尽管c-Jun氨基末端激酶(JNK)在OLT后迅速被激活,但JNK激活的功能后果尚不清楚。本研究的目的是使用选择性JNK抑制剂CC-401探讨OLT后JNK的作用。
在OLT前,通过动脉双袖带法对供体、受体或保存的肝外植体进行40小时冷保存,用载体或JNK抑制剂处理。评估受体30天生存率,并通过肝脏组织学、血清转氨酶、半胱天冬酶3激活、细胞溶质细胞色素c和脂质过氧化随时间评估移植物损伤。
OLT后,供体加保存和仅保存并用JNK抑制剂处理后的生存率增加(P<0.05)。仅处理受体并不能提高生存率。生存率的提高与肝脏组织学和血清天冬氨酸转氨酶水平的改善相关。JNK抑制在再灌注后60分钟显著降低非实质细胞杀伤(P<0.05),在再灌注后8小时显著降低中央周围坏死(P<0.01)。JNK抑制降低细胞色素c释放、半胱天冬酶3激活(P<0.05)和脂质过氧化(P<0.05)。JNK抑制还在再灌注后60分钟短暂阻断c-Jun磷酸化(P<0.05),而不影响其他丝裂原活化蛋白激酶信号传导,包括p-38和Erk激活。
JNK抑制可降低OLT后的肝脏坏死和凋亡,提示JNK激活通过两条途径促进细胞死亡。抑制JNK可能是预防移植后肝损伤的一种新的治疗策略。